{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:36:50Z","timestamp":1784867810638,"version":"3.55.0"},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Aminobisphosphonates may cause orbital\/ocular inflammation. Awareness of the clinical presentation and disease course is crucial. The purpose of this study was to analyse demographics, clinical presentation, disease course and treatment of aminobisphosphonate\u2010associated orbital\/ocular inflammation in a large series of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective study of patients with aminobisphosphonate\u2010associated orbital\/ocular inflammation and a literature review to differentiate disease presentation and course between various aminobisphosphonates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight patients from our institution (6 women and 2 men, median age 62\u00a0years) were included. The used drugs were zoledronate, alendronate and risedronate. The most common clinical presentation was conjunctival hyperaemia\/chemosis. Scleritis was the most common manifestation, followed by diffuse orbital inflammation and anterior uveitis. Ultrasound aided in diagnosis in all our patients. The aminobisphosphonate was halted in all patients, and some patients had anti\u2010inflammatory treatment. Literature review included 68 patients (83 eyes), of them the most abundant drugs causing orbital\/ocular inflammation were pamidronate (38 eyes) and zoledronate (35 eyes). Overall, among 76 patients, all drugs induced orbital disease, while uveitis was induced mostly by zoledronate and pamidronate, less by alendronate and not found among risedronate users. Time interval from drug administration to symptoms was hours to 28\u00a0days. Resolution was achieved in all patients, after 1\u201360\u00a0days from disease presentation, and the longer resolution period was found among alendronate users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Orbital\/ocular inflammation was mostly caused by intravenous aminobisphosphonates. Uveitis was not induced by risedronate. The putative aminobisphosphonate should be halted at the onset of orbital\/ocular involvement and prognosis is favourable.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aos.14063","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T10:08:52Z","timestamp":1551348532000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Aminobisphosphonate\u2010associated orbital and ocular inflammatory disease"],"prefix":"10.1111","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7891-2478","authenticated-orcid":false,"given":"Shay","family":"Keren","sequence":"first","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Leibovitch","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ben Cnaan","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meira","family":"Neudorfer","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortal","family":"Fogel","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona","family":"Greenman","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Shulman","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-444X","authenticated-orcid":false,"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-0286","authenticated-orcid":false,"given":"Zohar","family":"Habot\u2010Wilner","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Tel\u2010Aviv Sourasky Medical Center Affiliated to Sackler Faculty of Medicine Tel\u2010Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"American Academy of Ophthalmology.2018.Orbit eyelids and lacrimal system. Available at:https:\/\/store.aao.org\/2017-2018-basic-and-clinical-science-course-section-07-orbit-eyelids-and-lacrimal-system.html."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1986-1"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.053"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2012.681749"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1328337"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929866023408779"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.9.1032"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2013.09.023"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01840-8"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2035-z"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP11081.CR"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30188-2"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903043400914"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.384"},{"key":"e_1_2_5_18_1","first-page":"134","article-title":"A case series and review of bisphosphonate\u2010associated orbital inflammation","volume":"24","author":"Lefebvre DR","year":"2016","journal-title":"Ocular immunology and inflammation"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72902-2"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.12.1443"},{"key":"e_1_2_5_21_1","first-page":"837","article-title":"Ocular inflammation associated with alendronate therapy","volume":"117","author":"Mbekeani JN","year":"1999","journal-title":"Archives of ophthalmology (Chicago, Ill.\u202f: 1960)"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622310374783"},{"issue":"315","key":"e_1_2_5_23_1","first-page":"23","article-title":"Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma","author":"Missotten G","year":"2010","journal-title":"Bulletin de la Societe belge d'ophtalmologie"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155207080806"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2010.535641"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1226"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.10.028"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-015-0015-4"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00803"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2011.648818"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.17"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2015.1078380"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1048-1"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000225713.00630.e5"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.8.956"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21822"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.3129\/i09-110"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0803366"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.9.1335"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.09.008"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-0926-x"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31829f3b46"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3181c1a589"},{"key":"e_1_2_5_44_1","first-page":"50","article-title":"Zolendronate associated inflammatory orbital disease","volume":"123","author":"Yeo J","year":"2010","journal-title":"The New Zealand medical journal"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12995"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faos.14063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.14063","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T22:18:56Z","timestamp":1694211536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.14063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1111\/aos.14063"],"URL":"https:\/\/doi.org\/10.1111\/aos.14063","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"2018-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}